QTTB Q4 2021 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$73M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$802,000-18.2% YoY

Gross Profit

-$2M-198.6% margin

Operating Income

-$34M-4192.6% margin

Net Income

-$34M-4187.4% margin

EPS (Diluted)

$-10.58

QoQ Revenue Growth

-52.2%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$31M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$212M

Total Liabilities

$42M

Stockholders' Equity

$170M

Cash & Equivalents

$108M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$802,000	$980,000	-18.2%
Gross Profit	-$2M	$0	—
Operating Income	-$34M	-$30M	-12.8%
Net Income	-$34M	-$30M	-12.7%